CAR-T Immunotherapy and Non-small Cell Lung Cancer: Bottleneck and Dawn

CAR-T Immunotherapy and Non-small Cell Lung Cancer: Bottleneck and Dawn

With the deeper understanding of the pathophysiology and pathogenesis of non-small cell lung cancer (NSCLC) which threatens human health, NSCLC treatment has entered a new era. Transition from traditional treatment based on surgery, radiotherapy and chemotherapy to individualized and precise targete...

Full description

Bibliographic Details
Main Authors: Li ZHANG, Heng LI, Feiyue ZHANG, Shuting WANG, Gaofeng LI
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2020-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
chimeric antigen receptor modified t cells
target
toxicity
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2020.103.10

Similar Items

Similar Items